Result of Equity Issue

Proteome Sciences PLC
04 June 2004



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, OR INTO, THE UNITED STATES,
CANADA, AUSTRALIA OR JAPAN

                             Proteome Sciences plc

                               Results of Placing

Proteome Sciences plc is pleased to announce that the 1,848,739 new ordinary
shares have been successfully placed at 119 pence per share.  The placing is
conditional on Admission and dealings are expected to commence on 9 June 2004.



Enquiries:


Proteome Sciences plc
Christopher Pearce, Chief Executive                              01932 865065
James Malthouse, Finance Director

Dresdner Kleinwort Wasserstein
Michael Covington                                               020 7623 8000



This announcement has been issued by Proteome Sciences and is the sole
responsibility of Proteome Sciences. This announcement is for information
purposes only and does not constitute an offer to sell or issue any securities
or a solicitation of an offer to buy or acquire any securities or investment
advice in any jurisdiction including, without limitation, the United Kingdom,
the United States, Canada, Australia or Japan.

The Placing Shares have not been and will not be registered under the US
Securities Act of 1933 (the 'Securities Act') and may not be offered or sold
within the United States absent registration or an exemption from registration.
No public offering of securities will be made in the United States.

Dresdner Kleinwort Wasserstein Limited ('DrKW') and Dresdner Kleinwort
Wasserstein Securities Limited DrKWS, which are authorised and regulated by the
Financial Services Authority under the Financial Services and Markets Act 2000
('FSMA'), are acting for Proteome Sciences and for no one else in connection
with the Placing and will not be responsible to anyone other than Proteome
Sciences for providing the protections afforded to clients of DrKW and DrKWS,
nor for providing advice in relation to the Placing or any other matter referred
to in this announcement.

Neither this document nor any copy of it may be taken, transmitted or
distributed, directly or indirectly, in or into the United States, Canada,
Australia or Japan or in any jurisdiction in which such transmission or
distribution is unlawful. Any failure to comply with this restriction may
constitute a violation of US, Canadian, Australian or Japanese securities laws
or the securities laws of other states as the case may be.




                      This information is provided by RNS
            The company news service from the London Stock Exchange